Teva Pharmaceutical Industries Ltd.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $9.34B | $2.18B |
| Jun 2022 | — | $9.04B | $2.06B |
| Sep 2022 | — | $8.77B | $2.23B |
| Dec 2022 | — | $7.80B | $2.80B |
| Mar 2023 | — | $7.86B | $2.14B |
| Jun 2023 | — | $7.05B | $2.67B |
| Sep 2023 | — | $6.93B | $2.25B |
| Dec 2023 | — | $7.51B | $3.23B |
| Mar 2024 | — | $7.28B | $2.99B |
| Jun 2024 | — | $6.36B | $2.26B |
| Sep 2024 | — | $6.07B | $3.32B |
| Dec 2024 | — | $5.37B | $3.30B |
| Mar 2025 | — | $6.26B | $1.70B |
| Jun 2025 | — | $6.83B | $2.16B |
| Sep 2025 | — | $7.25B | $2.20B |
| Dec 2025 | — | $7.91B | $3.56B |
| Mar 2026 | — | $8.23B | $3.74B |
| Jun 2026 | — | $7.75B | $3.66B |